Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH2), CAS 170851-70-4, molecular weight 711.9 Da. It selectively activates the ghrelin receptor (GHSR-1a) with high specificity. Research examines its signaling effects without significant impact on cortisol or prolactin. Research compound — not for human use.
Compound Specifications
Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH₂), CAS 170851-70-4. Molecular weight 711.85 Da. It is a selective agonist of the ghrelin receptor (GHS-R1a) and is characterized by high selectivity in receptor-signaling assays without significant effects on other pituitary hormones. Research compound — not for human use.
Product Details
- Sizes: 5mg, 10mg
- Compound: Ipamorelin
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Purity: >99%
- Form: Lyophilized powder
- Testing: View COA (Verified by Janoshik) →
mg, 10mg
📚 View Published Research on Ipamorelin →
Peer-reviewed citations from PubMed — for educational purposes only
Ipamorelin documentation path
This Ipamorelin listing is organized for sequence identity, receptor-family context, and batch documentation before researchers compare the catalog record with published GH-axis literature.
- Identity: synthetic pentapeptide ghrelin-receptor agonist; sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2; CAS 170851-70-4.
- Documentation: review COA records and Quality & Testing for batch-verification standards.
- Literature context: see Ipamorelin research, Sermorelin research, and CJC-1295 + Ipamorelin research.
Research use only. This page does not provide dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance.